| Year |
Citation |
Score |
| 2021 |
Vahsen BF, Gray E, Thompson AG, Ansorge O, Anthony DC, Cowley SA, Talbot K, Turner MR. Non-neuronal cells in amyotrophic lateral sclerosis - from pathogenesis to biomarkers. Nature Reviews. Neurology. PMID 33927394 DOI: 10.1038/s41582-021-00487-8 |
0.483 |
|
| 2020 |
Thompson AG, Gray E, Mäger I, Thézénas ML, Charles PD, Talbot K, Fischer R, Kessler BM, Wood M, Turner MR. CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis. Clinical Proteomics. 17: 31. PMID 32821252 DOI: 10.1186/S12014-020-09294-7 |
0.335 |
|
| 2020 |
Feneberg E, Gordon D, Thompson AG, Finelli MJ, Dafinca R, Candalija A, Charles PD, Mäger I, Wood MJ, Fischer R, Kessler BM, Gray E, Turner MR, Talbot K. An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress. Neurobiology of Disease. 105050. PMID 32800996 DOI: 10.1016/J.Nbd.2020.105050 |
0.339 |
|
| 2020 |
Feneberg E, Turner MR, Ansorge O, Talbot K. Amyotrophic lateral sclerosis with a heterozygous D91A SOD1 variant and classical ALS-TDP neuropathology. Neurology. PMID 32769137 DOI: 10.1212/Wnl.0000000000010587 |
0.329 |
|
| 2020 |
Wang C, Foxley S, Ansorge O, Bangerter-Christensen S, Chiew M, Leonte A, Menke RA, Mollink J, Pallebage-Gamarallage M, Turner MR, Miller KL, Tendler BC. Methods for quantitative susceptibility and R2* mapping in whole post-mortem brains at 7T applied to amyotrophic lateral sclerosis. Neuroimage. 117216. PMID 32745677 DOI: 10.1016/J.Neuroimage.2020.117216 |
0.305 |
|
| 2020 |
Gray E, Thompson AG, Wuu J, Pelt J, Talbot K, Benatar M, Turner MR. CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. PMID 32666680 DOI: 10.1002/Acn3.51114 |
0.325 |
|
| 2020 |
Nolan M, Scott C, Gamarallage MP, Lunn D, Carpenter K, McDonough E, Meyer D, Kaanumalle S, Santamaria-Pang A, Turner MR, Talbot K, Ansorge O. Quantitative patterns of motor cortex proteinopathy across ALS genotypes. Acta Neuropathologica Communications. 8: 98. PMID 32616036 DOI: 10.1186/S40478-020-00961-2 |
0.361 |
|
| 2020 |
Kelly M, Lavrov A, Garcia-Gancedo L, Parr J, Hart R, Chiwera T, Shaw CE, Al-Chalabi A, Marsden R, Turner MR, Talbot K. The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-11. PMID 32573278 DOI: 10.1080/21678421.2020.1773501 |
0.326 |
|
| 2020 |
Gray E, Oeckl P, Amador MDM, Andreasson U, An J, Blennow K, Bowser R, De Schaepdryver M, Heslegrave A, Kuhle J, Maceski A, Koel-Simmelink M, Lamari F, Lombardi V, Malaspina A, ... ... Turner MR, et al. A multi-center study of neurofilament assay reliability and inter-laboratory variability. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-7. PMID 32558597 DOI: 10.1080/21678421.2020.1779300 |
0.318 |
|
| 2020 |
Ababneh NA, Scaber J, Flynn R, Douglas A, Barbagallo P, Candalija A, Turner MR, Sims D, Dafinca R, Cowley SA, Talbot K. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair. Human Molecular Genetics. PMID 32504093 DOI: 10.1093/Hmg/Ddaa106 |
0.356 |
|
| 2020 |
Turner MR, Talbot K. Primary lateral sclerosis: diagnosis and management. Practical Neurology. PMID 32217663 DOI: 10.1136/Practneurol-2019-002300 |
0.319 |
|
| 2020 |
Tu S, Wang C, Menke RAL, Talbot K, Barnett M, Kiernan MC, Turner MR. Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-7. PMID 32106716 DOI: 10.1080/21678421.2020.1733020 |
0.348 |
|
| 2020 |
Swash M, Burke D, Turner MR, Grosskreutz J, Leigh PN, deCarvalho M, Kiernan MC. Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 91: 227-234. PMID 32054724 DOI: 10.1136/Jnnp-2019-321938 |
0.379 |
|
| 2020 |
Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, Ravits J, Silani V, Simmons Z, Statland J, van den Berg LH, Mitsumoto H. Primary lateral sclerosis: consensus diagnostic criteria. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32029539 DOI: 10.1136/Jnnp-2019-322541 |
0.326 |
|
| 2019 |
Thompson AG, Turner MR. Untangling neuroinflammation in amyotrophiclateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31296587 DOI: 10.1136/Jnnp-2019-321242 |
0.347 |
|
| 2019 |
Turner MR. The early biomarker challenge in neurodegenerative disorders. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31243045 DOI: 10.1136/Jnnp-2019-321145 |
0.311 |
|
| 2019 |
Thompson AG, Gray E, Bampton A, Raciborska D, Talbot K, Turner MR. CSF chitinase proteins in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31123140 DOI: 10.1136/Jnnp-2019-320442 |
0.304 |
|
| 2019 |
Edmond EC, Stagg CJ, Turner MR. Therapeutic non-invasive brain stimulation in amyotrophic lateral sclerosis: rationale, methods and experience. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 31072957 DOI: 10.1136/Jnnp-2018-320213 |
0.337 |
|
| 2019 |
Benatar M, Turner MR, Wuu J. Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-7. PMID 30892087 DOI: 10.1080/21678421.2019.1587634 |
0.356 |
|
| 2019 |
Khalaf R, Martin S, Ellis C, Burman R, Sreedharan J, Shaw C, Leigh PN, Turner MR, Al-Chalabi A. Relative preservation of triceps over biceps strength in upper limb-onset ALS: the 'split elbow'. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30846542 DOI: 10.1136/Jnnp-2018-319894 |
0.344 |
|
| 2019 |
Allen SP, Hall B, Castelli LM, Francis L, Woof R, Siskos AP, Kouloura E, Gray E, Thompson AG, Talbot K, Higginbottom A, Myszczynska M, Allen CF, Stopford MJ, Hemingway J, ... ... Turner MR, et al. Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain : a Journal of Neurology. PMID 30698736 DOI: 10.1093/Brain/Awy353 |
0.32 |
|
| 2019 |
Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR. Cerebellar tract alterations in PLS and ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-4. PMID 30663900 DOI: 10.1080/21678421.2018.1562554 |
0.356 |
|
| 2019 |
Tu S, Turner MR, Kiernan MC. 017 Widespread extra-motor abnormality is a prominent MRI signature of ALS: a cross-cohort study Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Anzan.17 |
0.376 |
|
| 2019 |
Robertson J, Gray E, Thompson A, Feneberg E, Talbot K, Turner M. 004 A triaging blood test for neurology? Serum neurofilament levels in a cohort of GP referrals Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.38 |
0.316 |
|
| 2019 |
Edmond EC, Menke R, Proudfoot M, Talbot K, Stagg CJ, Turner MR. Motor System Biomarkers In Amyotrophic Lateral Sclerosis Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Abn-2.213 |
0.378 |
|
| 2018 |
Proudfoot M, Bede P, Turner MR. Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis. Frontiers in Neurology. 9: 1148. PMID 30671016 DOI: 10.3389/Fneur.2018.01148 |
0.355 |
|
| 2018 |
Turner MR. The reunification of amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30297521 DOI: 10.1136/Jnnp-2018-319470 |
0.37 |
|
| 2018 |
Talbot K, Feneberg E, Scaber J, Thompson AG, Turner MR. Amyotrophic lateral sclerosis: the complex path to precision medicine. Journal of Neurology. PMID 30054789 DOI: 10.1007/S00415-018-8983-8 |
0.375 |
|
| 2018 |
Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR. Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30049750 DOI: 10.1136/Jnnp-2018-318625 |
0.321 |
|
| 2018 |
Salter M, Corfield E, Ramadass A, Grand F, Green J, Westra J, Lim CR, Farrimond L, Feneberg E, Scaber J, Thompson A, Ossher L, Turner M, Talbot K, Cudkowicz M, et al. Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis. Ebiomedicine. PMID 29941342 DOI: 10.1016/J.Ebiom.2018.06.015 |
0.343 |
|
| 2018 |
Henderson RD, Garton FC, Kiernan MC, Turner MR, Eisen A. Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29666205 DOI: 10.1136/Jnnp-2017-317245 |
0.378 |
|
| 2018 |
Proudfoot M, Colclough GL, Quinn A, Wuu J, Talbot K, Benatar M, Nobre AC, Woolrich MW, Turner MR. Increased cerebral functional connectivity in ALS: A resting-state magnetoencephalography study. Neurology. 90: e1418-e1424. PMID 29661904 DOI: 10.1212/Wnl.0000000000005333 |
0.331 |
|
| 2018 |
Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, ... ... Turner MR, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. The Lancet. Neurology. PMID 29598923 DOI: 10.1016/S1474-4422(18)30089-9 |
0.335 |
|
| 2018 |
Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, ... ... Turner MR, et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron. 97: 1268-1283.e6. PMID 29566793 DOI: 10.1016/J.Neuron.2018.02.027 |
0.339 |
|
| 2018 |
Pallebage-Gamarallage M, Foxley S, Menke RAL, Huszar IN, Jenkinson M, Tendler BC, Wang C, Jbabdi S, Turner MR, Miller KL, Ansorge O. Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. Bmc Neuroscience. 19: 11. PMID 29529995 DOI: 10.1186/S12868-018-0416-1 |
0.358 |
|
| 2018 |
Feneberg E, Gray E, Ansorge O, Talbot K, Turner MR. Towards a TDP-43-Based Biomarker for ALS and FTLD. Molecular Neurobiology. PMID 29460270 DOI: 10.1007/S12035-018-0947-6 |
0.394 |
|
| 2018 |
Thompson AG, Gray E, Thézénas ML, Charles PD, Evetts S, Hu MT, Talbot K, Fischer R, Kessler BM, Turner MR. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Annals of Neurology. PMID 29331073 DOI: 10.1002/Ana.25143 |
0.346 |
|
| 2018 |
Menke RAL, Proudfoot M, Talbot K, Turner MR. The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. Neuroimage. Clinical. 17: 953-961. PMID 29321969 DOI: 10.1016/J.Nicl.2017.12.025 |
0.321 |
|
| 2017 |
Feneberg E, Oeckl P, Steinacker P, Verde F, Barro C, Van Damme P, Gray E, Grosskreutz J, Jardel C, Kuhle J, Koerner S, Lamari F, Amador MDM, Mayer B, Morelli C, ... ... Turner MR, et al. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology. PMID 29212830 DOI: 10.1212/Wnl.0000000000004761 |
0.31 |
|
| 2017 |
Turner MR, Eisen A, Kiernan MC, Ravits J, Swash M. Kinnier Wilson's puzzling features of amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29122933 DOI: 10.1136/Jnnp-2017-317217 |
0.366 |
|
| 2017 |
Turner MR. Non-invasive in vivo neuropathology of the C9orf72-related ALS-FTD syndrome. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29054918 DOI: 10.1136/Jnnp-2017-317010 |
0.381 |
|
| 2017 |
Turner MR, Al-Chalabi A, Chio A, Hardiman O, Kiernan MC, Rohrer JD, Rowe J, Seeley W, Talbot K. Genetic screening in sporadic ALS and FTD. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28642287 DOI: 10.1136/Jnnp-2017-315995 |
0.307 |
|
| 2017 |
Fabes J, Matthews L, Filippini N, Talbot K, Jenkinson M, Turner MR. Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis. Academic Radiology. PMID 28572001 DOI: 10.1016/J.Acra.2017.04.008 |
0.322 |
|
| 2017 |
Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, King A, Ticozzi N, Kenna KP, Soragia-Gkazi A, Miller JW, Sato A, Dias DM, Jeon M, Vance C, ... ... Turner MR, et al. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Science Translational Medicine. 9. PMID 28469040 DOI: 10.1126/Scitranslmed.Aad9157 |
0.307 |
|
| 2017 |
Aoki Y, Manzano R, Lee Y, Dafinca R, Aoki M, Douglas AG, Varela MA, Sathyaprakash C, Scaber J, Barbagallo P, Vader P, Mäger I, Ezzat K, Turner MR, Ito N, et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain : a Journal of Neurology. PMID 28334866 DOI: 10.1016/S0960-8966(17)30312-7 |
0.344 |
|
| 2017 |
Turner MR. Is cardiovascular fitness a risk factor for ALS? Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28292783 DOI: 10.1136/Jnnp-2017-315606 |
0.352 |
|
| 2017 |
Thompson AG, Blackwell V, Marsden R, Millard E, Lawson C, Nickol AH, East JE, Talbot K, Allan PJ, Turner MR. A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 28100064 DOI: 10.1080/21678421.2016.1274330 |
0.312 |
|
| 2017 |
Turner MR, Talbot K. Sweet food preference in amyotrophic lateral sclerosis. Practical Neurology. PMID 28073920 DOI: 10.1136/Practneurol-2016-001554 |
0.317 |
|
| 2017 |
Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, HortobáGyi T, Rosenfeld J, Silani V, Ince PG, Turner MR. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-22. PMID 28054827 DOI: 10.1080/21678421.2016.1267768 |
0.346 |
|
| 2016 |
Turner MR, Menke RA. The tough body at the epicentre of amyotrophic lateral sclerosis The corpus callosum is a signpost to the interhemispheric highways underpinning the widespread cerebral pathology that typifies the syndrome of ALS. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27965396 DOI: 10.1136/Jnnp-2016-315247 |
0.372 |
|
| 2016 |
Turner MR. Motor neuron disease: biomarker development for an expanding cerebral syndrome. Clinical Medicine (London, England). 16: s60-s65. PMID 27956443 DOI: 10.7861/Clinmedicine.16-6-S60 |
0.341 |
|
| 2016 |
Turner MR, Goldacre R, Talbot K, Goldacre MJ. Psychiatric disorders prior to amyotrophic lateral sclerosis. Annals of Neurology. PMID 27761925 DOI: 10.1002/Ana.24801 |
0.304 |
|
| 2016 |
Menke RA, Agosta F, Grosskreutz J, Filippi M, Turner MR. Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 27752938 DOI: 10.1007/S13311-016-0484-9 |
0.368 |
|
| 2016 |
Proudfoot M, Rohenkohl G, Quinn A, Colclough GL, Wuu J, Talbot K, Woolrich MW, Benatar M, Nobre AC, Turner MR. Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis. Human Brain Mapping. PMID 27623516 DOI: 10.1002/Hbm.23357 |
0.322 |
|
| 2016 |
Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, van Rheenen W, van Eijk KR, Jones AR, Keagle P, Shatunov A, Sproviero W, Smith BN, van Es MA, Topp SD, ... ... Turner MR, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nature Genetics. PMID 27455347 DOI: 10.1038/Ng.3626 |
0.341 |
|
| 2016 |
Oeckl P, Jardel C, Salachas F, Lamari F, Andersen PM, Bowser R, de Carvalho M, Costa J, van Damme P, Gray E, Grosskreutz J, Hernández-Barral M, Herukka SK, Huss A, Jeromin A, ... ... Turner MR, et al. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 17: 404-413. PMID 27415180 DOI: 10.3109/21678421.2016.1167913 |
0.321 |
|
| 2016 |
McDermott CJ, Bradburn MJ, Maguire C, Cooper CL, Baird WO, Baxter SK, Cohen J, Cantrill H, Dixon S, Ackroyd R, Baudouin S, Bentley A, Berrisford R, Bianchi S, Bourke SC, ... ... Turner M, et al. DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial. Health Technology Assessment (Winchester, England). 20: 1-186. PMID 27353839 DOI: 10.3310/Hta20450 |
0.31 |
|
| 2016 |
Huynh W, Simon NG, Grosskreutz J, Turner MR, Vucic S, Kiernan MC. Assessment of the upper motor neuron in amyotrophic lateral sclerosis. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 127: 2643-60. PMID 27291884 DOI: 10.1016/J.Clinph.2016.04.025 |
0.367 |
|
| 2016 |
Pattinson KT, Turner MR. A wider pathological network underlying breathlessness and respiratory failure in amyotrophic lateral sclerosis. The European Respiratory Journal. 47: 1632-4. PMID 27246080 DOI: 10.1183/13993003.00321-2016 |
0.3 |
|
| 2016 |
Rutter-Locher Z, Turner MR, Leigh PN, Al-Chalabi A. Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-5. PMID 27188215 DOI: 10.1080/21678421.2016.1181766 |
0.362 |
|
| 2016 |
Thompson AG, Gray E, Heman-Ackah SM, Mäger I, Talbot K, Andaloussi SE, Wood MJ, Turner MR. Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nature Reviews. Neurology. PMID 27174238 DOI: 10.1038/Nrneurol.2016.68 |
0.325 |
|
| 2016 |
Turner M, Cosgrove J, Jamieson S, Chowdhury FU. Teaching Neuroimages: Hypometabolism of the primary motor cortex in primary lateral sclerosis: The stripe sign. Neurology. 86: 1464. PMID 27163663 DOI: 10.1212/Wnl.0000000000002600 |
0.338 |
|
| 2016 |
Dafinca R, Scaber J, Ababneh N, Lalic T, Weir G, Christian H, Vowles J, Douglas AG, Fletcher-Jones A, Browne C, Nakanishi M, Turner MR, Wade-Martins R, Cowley SA, Talbot K. C9orf72 Hexanucleotide Expansions are Associated with Altered ER Calcium Homeostasis and Stress Granule Formation in iPSC-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Stem Cells (Dayton, Ohio). PMID 27097283 DOI: 10.1002/Stem.2388 |
0.36 |
|
| 2016 |
Müller HP, Turner MR, Grosskreutz J, Abrahams S, Bede P, Govind V, Prudlo J, Ludolph AC, Filippi M, Kassubek J. A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26746186 DOI: 10.1136/Jnnp-2015-311952 |
0.369 |
|
| 2016 |
Mattsson N, Schott JM, Hardy J, Turner MR, Zetterberg H. Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26746185 DOI: 10.1136/Jnnp-2015-311321 |
0.327 |
|
| 2016 |
Menke RA, Proudfoot M, Wuu J, Andersen PM, Talbot K, Benatar M, Turner MR. Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26733601 DOI: 10.1136/Jnnp-2015-311945 |
0.317 |
|
| 2016 |
Proudfoot M, Rohenkohl G, Gould I, Wuu J, Andersen PM, Talbot K, Woolrich MW, Benatar M, Nobre AC, Turner MR. Changes in cortical β-oscillation dynamics across the clinical spectrum of motor neuron disease The Lancet. 387: S84. DOI: 10.1016/S0140-6736(16)00471-2 |
0.339 |
|
| 2016 |
Kassubek J, Turner M, Grosskreutz J, Abrahams S, Bede P, Agosta F, Govind V, Prudlo J, Ludolph A, Filippi M, Müller H. ID 231 – Multicentric structural connectome analysis in 240 patients with amyotrophic lateral sclerosis Clinical Neurophysiology. 127: e76-e77. DOI: 10.1016/J.Clinph.2015.11.255 |
0.359 |
|
| 2015 |
Kiernan MC, Turner MR. Lou Gehrig and the ALS split hand. Neurology. 85: 1995. PMID 26628488 DOI: 10.1212/Wnl.0000000000002172 |
0.31 |
|
| 2015 |
Webb LM, Datta P, Bell SE, Kitamura D, Turner M, Butcher GW. GIMAP1 Is Essential for the Survival of Naive and Activated B Cells In Vivo. Journal of Immunology (Baltimore, Md. : 1950). PMID 26621859 DOI: 10.4049/Jimmunol.1501582 |
0.314 |
|
| 2015 |
Turner MR, Gray E. Are neurofilaments heading for the ALS clinic? Neurofilaments in ALS diagnostics need further prospective appraisal, but are a frontrunner as a potential outcome measure in therapeutic trials. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26438577 DOI: 10.1136/Jnnp-2015-311934 |
0.373 |
|
| 2015 |
Verstraete E, Turner MR, Grosskreutz J, Filippi M, Benatar M. Mind the gap: The mismatch between clinical and imaging metrics in ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 26402254 DOI: 10.3109/21678421.2015.1051989 |
0.336 |
|
| 2015 |
Newman R, Turner M. The Role of p110δ in the Development and Activation of B Lymphocytes. Advances in Experimental Medicine and Biology. 850: 119-35. PMID 26324350 DOI: 10.1007/978-3-319-15774-0_9 |
0.304 |
|
| 2015 |
Menke RA, Gray E, Lu CH, Kuhle J, Talbot K, Malaspina A, Turner MR. CSF neurofilament light chain reflects corticospinal tract degeneration in ALS. Annals of Clinical and Translational Neurology. 2: 748-55. PMID 26273687 DOI: 10.1002/Acn3.212 |
0.35 |
|
| 2015 |
Turner MR, Goldacre R, Talbot K, Goldacre MJ. Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26260352 DOI: 10.1136/Jnnp-2015-311157 |
0.306 |
|
| 2015 |
Gray E, Larkin JR, Claridge TD, Talbot K, Sibson NR, Turner MR. The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 26121274 DOI: 10.3109/21678421.2015.1053490 |
0.6 |
|
| 2015 |
van der Kleij LA, Jones AR, Steen IN, Young CA, Shaw PJ, Shaw CE, Leigh PN, Turner MR, Al-Chalabi A. Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-6. PMID 26083873 DOI: 10.3109/21678421.2015.1051987 |
0.352 |
|
| 2015 |
Turner MR, Verstraete E. What does imaging reveal about the pathology of amyotrophic lateral sclerosis? Current Neurology and Neuroscience Reports. 15: 45. PMID 26008817 DOI: 10.1007/S11910-015-0569-6 |
0.372 |
|
| 2015 |
Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, ... Turner MR, et al. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 84: 2247-57. PMID 25934855 DOI: 10.1212/Wnl.0000000000001642 |
0.345 |
|
| 2015 |
Eisen A, Lemon R, Kiernan MC, Hornberger M, Turner MR. Does dysfunction of the mirror neuron system contribute to symptoms in amyotrophic lateral sclerosis? Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 126: 1288-1294. PMID 25727900 DOI: 10.1016/J.Clinph.2015.02.003 |
0.338 |
|
| 2015 |
Turner MR, Swash M. The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 667-73. PMID 25644224 DOI: 10.1136/Jnnp-2014-308946 |
0.368 |
|
| 2015 |
Turner MR, Kiernan MC. The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 481-2. PMID 25550412 DOI: 10.1136/Jnnp-2014-309829 |
0.306 |
|
| 2015 |
Turner MR, Benatar M. Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle & Nerve. 51: 14-8. PMID 25288265 DOI: 10.1002/Mus.24470 |
0.353 |
|
| 2015 |
Müller H-, Grön G, Abrahams S, Bede P, Filippi M, Agosta F, Govind V, Grosskreutz J, Prudlo J, Turner MR, Kassubek J. V15. Ex post facto structural connectome analysis in ALS at multicenter level: Analysis of over 400 data sets from 8 centers Clinical Neurophysiology. 126. DOI: 10.1016/J.Clinph.2015.04.093 |
0.338 |
|
| 2014 |
Okkenhaug K, Turner M, Gold MR. PI3K Signaling in B Cell and T Cell Biology. Frontiers in Immunology. 5: 557-557. PMID 25404931 DOI: 10.3389/Fimmu.2014.00557 |
0.313 |
|
| 2014 |
Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP, Scotter EL, Kost J, Keagle P, Miller JW, Calini D, Vance C, Danielson EW, Troakes C, Tiloca C, ... ... Turner MR, et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron. 84: 324-31. PMID 25374358 DOI: 10.1016/J.Neuron.2014.09.027 |
0.313 |
|
| 2014 |
Webb LM, Pascall JC, Hepburn L, Carter C, Turner M, Butcher GW. Generation and characterisation of mice deficient in the multi-GTPase domain containing protein, GIMAP8. Plos One. 9: e110294. PMID 25329815 DOI: 10.1371/Journal.Pone.0110294 |
0.314 |
|
| 2014 |
Dickens AM, Larkin JR, Griffin JL, Cavey A, Matthews L, Turner MR, Wilcock GK, Davis BG, Claridge TD, Palace J, Anthony DC, Sibson NR. A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology. 83: 1492-9. PMID 25253748 DOI: 10.1212/Wnl.0000000000000905 |
0.657 |
|
| 2014 |
Simon NG, Turner MR, Vucic S, Al-Chalabi A, Shefner J, Lomen-Hoerth C, Kiernan MC. Quantifying disease progression in amyotrophic lateral sclerosis. Annals of Neurology. 76: 643-57. PMID 25223628 DOI: 10.1002/Ana.24273 |
0.357 |
|
| 2014 |
Hartung V, Prell T, Gaser C, Turner MR, Tietz F, Ilse B, Bokemeyer M, Witte OW, Grosskreutz J. Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis. Plos One. 9: e104894. PMID 25133577 DOI: 10.1371/Journal.Pone.0104894 |
0.345 |
|
| 2014 |
Menke RA, Körner S, Filippini N, Douaud G, Knight S, Talbot K, Turner MR. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain : a Journal of Neurology. 137: 2546-55. PMID 24951638 DOI: 10.1093/Brain/Awu162 |
0.35 |
|
| 2014 |
Evans MC, Gaillard PJ, de Boer M, Appeldoorn C, Dorland R, Sibson NR, Turner MR, Anthony DC, Stolp HB. CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis. Acta Neuropathologica Communications. 2: 66. PMID 24923195 DOI: 10.1186/2051-5960-2-66 |
0.723 |
|
| 2014 |
Evans MC, Serres S, Khrapitchev AA, Stolp HB, Anthony DC, Talbot K, Turner MR, Sibson NR. T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 34: 785-93. PMID 24496176 DOI: 10.1038/Jcbfm.2014.19 |
0.719 |
|
| 2014 |
Bäumer D, Talbot K, Turner MR. Advances in motor neurone disease. Journal of the Royal Society of Medicine. 107: 14-21. PMID 24399773 DOI: 10.1177/0141076813511451 |
0.394 |
|
| 2014 |
Bäumer D, Butterworth R, Menke RA, Talbot K, Hofer M, Turner MR. Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis. Neurology. 82: 457-8. PMID 24363135 DOI: 10.1212/Wnl.0000000000000090 |
0.374 |
|
| 2014 |
Eisen A, Turner MR, Lemon R. Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis. Muscle & Nerve. 49: 469-77. PMID 24273101 DOI: 10.1002/Mus.24132 |
0.312 |
|
| 2014 |
Proudfoot M, Rohenkohl G, Gould I, Woolrich M, Wu J, Nobre AC, Benatar M, Turner M. Magnetoencephalographic evidence of cortical motor dysfunction in ALS F1000research. 5. DOI: 10.7490/F1000Research.1097350.1 |
0.313 |
|
| 2013 |
Fekete T, Zach N, Mujica-Parodi LR, Turner MR. Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis. Plos One. 8: e85190. PMID 24391997 DOI: 10.1371/Journal.Pone.0085190 |
0.331 |
|
| 2013 |
Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ. Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology. 81: 1222-5. PMID 23946298 DOI: 10.1212/Wnl.0B013E3182A6Cc13 |
0.344 |
|
| 2013 |
Foerster BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, Churchill CL, Mohamed MA, Bartels C, Benatar M, Bonzano L, Ciccarelli O, Cosottini M, Ellis CM, Ehrenreich H, Filippini N, ... ... Turner MR, et al. Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Academic Radiology. 20: 1099-106. PMID 23931423 DOI: 10.1016/J.Acra.2013.03.017 |
0.309 |
|
| 2013 |
Eisen A, Turner MR. Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level? Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 487-93. PMID 23879681 DOI: 10.3109/21678421.2013.812660 |
0.338 |
|
| 2013 |
Chad DA, Rowland LP, Armon C, Bedlack R, Durham H, Factor-Litvak P, Heiman-Patterson T, Heitzman D, Lacomis D, Ludolph A, Maragakis N, Miller R, Pattee G, Shoesmith C, Sorenson E, ... Turner MR, et al. Peer recommendations on how to improve clinical research, and Conference wrap-up. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 67-73. PMID 23678882 DOI: 10.3109/21678421.2013.778605 |
0.316 |
|
| 2013 |
Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, Manfredi G, Maragakis N, Miller RG, Pullman SL, Rutkove SB, Shaw PJ, Shefner J, Fischbeck KH. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 19-32. PMID 23678877 DOI: 10.3109/21678421.2013.778554 |
0.387 |
|
| 2013 |
Kolind S, Sharma R, Knight S, Johansen-Berg H, Talbot K, Turner MR. Myelin imaging in amyotrophic and primary lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 562-73. PMID 23678852 DOI: 10.3109/21678421.2013.794843 |
0.369 |
|
| 2013 |
Turner MR, Talbot K. Mimics and chameleons in motor neurone disease. Practical Neurology. 13: 153-64. PMID 23616620 DOI: 10.1136/Practneurol-2013-000557 |
0.315 |
|
| 2013 |
Fang F, Al-Chalabi A, Ronnevi LO, Turner MR, Wirdefeldt K, Kamel F, Ye W. Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 14: 362-8. PMID 23527497 DOI: 10.3109/21678421.2013.775309 |
0.312 |
|
| 2013 |
Morrison KE, Dhariwal S, Hornabrook R, Savage L, Burn DJ, Khoo TK, Kelly J, Murphy CL, Al-Chalabi A, Dougherty A, Leigh PN, Wijesekera L, Thornhill M, Ellis CM, ... ... Turner MR, et al. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 12: 339-45. PMID 23453347 DOI: 10.1016/S1474-4422(13)70037-1 |
0.326 |
|
| 2013 |
Turner MR. Increased premorbid physical activity and amyotrophic lateral sclerosis: born to run rather than run to death, or a seductive myth? Journal of Neurology, Neurosurgery, and Psychiatry. 84: 947. PMID 23447649 DOI: 10.1136/Jnnp-2013-304935 |
0.373 |
|
| 2013 |
Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, et al. Controversies and priorities in amyotrophic lateral sclerosis. The Lancet. Neurology. 12: 310-22. PMID 23415570 DOI: 10.1016/S1474-4422(13)70036-X |
0.366 |
|
| 2013 |
Kent L, Davies P, Kennett R, Wimalaratna S, Kerr R, Turner MR, Talbot K. Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy. Journal of Neurology. 260: 1166-7. PMID 23400499 DOI: 10.1007/S00415-013-6854-X |
0.357 |
|
| 2013 |
Stagg CJ, Knight S, Talbot K, Jenkinson M, Maudsley AA, Turner MR. Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS. Neurology. 80: 610-5. PMID 23325907 DOI: 10.1212/Wnl.0B013E318281Ccec |
0.301 |
|
| 2013 |
Evans MC, Couch Y, Sibson N, Turner MR. Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Molecular and Cellular Neurosciences. 53: 34-41. PMID 23110760 DOI: 10.1016/J.Mcn.2012.10.008 |
0.681 |
|
| 2012 |
Turner MR, Talbot K. Motor neurone disease is a clinical diagnosis. Practical Neurology. 12: 396-7. PMID 23144309 DOI: 10.1136/Practneurol-2012-000374 |
0.323 |
|
| 2012 |
Menke RA, Abraham I, Thiel CS, Filippini N, Knight S, Talbot K, Turner MR. Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Archives of Neurology. 69: 1493-9. PMID 22910997 DOI: 10.1001/Archneurol.2012.1122 |
0.301 |
|
| 2012 |
Turner MR, Agosta F, Bede P, Govind V, Lulé D, Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomarkers in Medicine. 6: 319-37. PMID 22731907 DOI: 10.2217/Bmm.12.26 |
0.318 |
|
| 2012 |
Turner MR, Barnwell J, Al-Chalabi A, Eisen A. Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain : a Journal of Neurology. 135: 2883-91. PMID 22661746 DOI: 10.1093/Brain/Aws144 |
0.301 |
|
| 2012 |
Turner MR, Kiernan MC. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis? Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 245-50. PMID 22424125 DOI: 10.3109/17482968.2011.636050 |
0.357 |
|
| 2012 |
Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Wijesekera L, Turner MR, Leigh PN, Shaw CE, Al-Chalabi A. A proposed staging system for amyotrophic lateral sclerosis. Brain : a Journal of Neurology. 135: 847-52. PMID 22271664 DOI: 10.1093/Brain/Awr351 |
0.321 |
|
| 2012 |
Webb GJ, Turner MR, Craig SE. Teaching NeuroImages: somatic muscle fasciculations detected by electrocardiography. Neurology. 78: e19. PMID 22249505 DOI: 10.1212/Wnl.0B013E31823Fcdb9 |
0.309 |
|
| 2012 |
Otto M, Bowser R, Turner M, Berry J, Brettschneider J, Connor J, Costa J, Cudkowicz M, Glass J, Jahn O, Lehnert S, Malaspina A, Parnetti L, Petzold A, Shaw P, et al. Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 1-10. PMID 22214350 DOI: 10.3109/17482968.2011.627589 |
0.343 |
|
| 2012 |
Evans MC, Modo M, Talbot K, Sibson N, Turner MR. Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 288-301. PMID 22117132 DOI: 10.3109/17482968.2011.623300 |
0.545 |
|
| 2012 |
Turner MR, Wotton C, Talbot K, Goldacre MJ. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 395-8. PMID 22072701 DOI: 10.1136/Jnnp-2011-301161 |
0.316 |
|
| 2011 |
Douaud G, Filippini N, Knight S, Talbot K, Turner MR. Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain : a Journal of Neurology. 134: 3470-9. PMID 22075069 DOI: 10.1093/Brain/Awr279 |
0.314 |
|
| 2011 |
Bowser R, Turner MR, Shefner J. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nature Reviews. Neurology. 7: 631-8. PMID 21989244 DOI: 10.1038/Nrneurol.2011.151 |
0.366 |
|
| 2011 |
Sharma R, Hicks S, Berna CM, Kennard C, Talbot K, Turner MR. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Archives of Neurology. 68: 857-61. PMID 21747027 DOI: 10.1001/Archneurol.2011.130 |
0.375 |
|
| 2011 |
Vivekananda U, Manjalay ZR, Ganesalingam J, Simms J, Shaw CE, Leigh PN, Turner MR, Al-Chalabi A. Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 635-7. PMID 21551173 DOI: 10.1136/Jnnp.2010.237412 |
0.311 |
|
| 2011 |
Blain CR, Brunton S, Williams VC, Leemans A, Turner MR, Andersen PM, Catani M, Stanton BR, Ganesalingham J, Jones DK, Williams SC, Leigh PN, Simmons A. Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 843-9. PMID 21515558 DOI: 10.1136/Jnnp.2010.236018 |
0.357 |
|
| 2011 |
Turner MR. MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers? Biomarkers in Medicine. 5: 79-81. PMID 21319968 DOI: 10.2217/Bmm.10.120 |
0.416 |
|
| 2011 |
Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, Talbot K, Al-Chalabi A. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 853-4. PMID 20562391 DOI: 10.1136/Jnnp.2010.208413 |
0.356 |
|
| 2010 |
Turner MR, Modo M. Advances in the application of MRI to amyotrophic lateral sclerosis. Expert Opinion On Medical Diagnostics. 4: 483-496. PMID 21516259 DOI: 10.1517/17530059.2010.536836 |
0.332 |
|
| 2010 |
Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology. 75: 1645-52. PMID 21041787 DOI: 10.1212/Wnl.0B013E3181Fb84D1 |
0.366 |
|
| 2010 |
Bäumer D, Hilton D, Paine SM, Turner MR, Lowe J, Talbot K, Ansorge O. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 75: 611-8. PMID 20668261 DOI: 10.1212/Wnl.0B013E3181Ed9Cde |
0.365 |
|
| 2010 |
Turner MR, Swash M, Ebers GC. Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis. Brain : a Journal of Neurology. 133: 3470-9. PMID 20576696 DOI: 10.1093/Brain/Awq097 |
0.357 |
|
| 2010 |
Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 294: 81-5. PMID 20452624 DOI: 10.1016/J.Jns.2010.03.028 |
0.34 |
|
| 2010 |
Henderson RB, Grys K, Vehlow A, De Bettignies C, Zachacz A, Henley T, Turner M, Batista F, Tybulewicz VLJ. A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival Journal of Experimental Medicine. 207: 837-853. PMID 20308364 DOI: 10.1084/Jem.20091489 |
0.312 |
|
| 2010 |
Turner MR, Brockington A, Scaber J, Hollinger H, Marsden R, Shaw PJ, Talbot K. Pattern of spread and prognosis in lower limb-onset ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 369-73. PMID 20001488 DOI: 10.3109/17482960903420140 |
0.324 |
|
| 2010 |
Turner MR, Abisgold J, Yeates DG, Talbot K, Goldacre MJ. Head and other physical trauma requiring hospitalisation is not a significant risk factor in the development of ALS. Journal of the Neurological Sciences. 288: 45-8. PMID 19878957 DOI: 10.1016/J.Jns.2009.10.010 |
0.304 |
|
| 2010 |
Pereira EA, Turner MR, Wass JA, Talbot K. Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 11: 255-7. PMID 19634028 DOI: 10.3109/17482960902870985 |
0.353 |
|
| 2010 |
Talbot K, Lowe J, Ansorge O, Hilton D, Baumer D, Paine S, Turner M. PATU5 Characterisation of fused in sarcoma pathology and FUS mutations in juvenile amyotrophic lateral sclerosis with basophilic inclusions Journal of Neurology, Neurosurgery & Psychiatry. 81: e25-e25. DOI: 10.1136/Jnnp.2010.226340.34 |
0.363 |
|
| 2010 |
Talbot K, Turner MR. PORT02 Oxford motor neurone disorders research Journal of Neurology, Neurosurgery, and Psychiatry. 81. DOI: 10.1136/Jnnp.2010.226340.197 |
0.334 |
|
| 2010 |
Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. PATH44 Corpus callosum diffusion tensor imaging as a biomarker for motor neurone disease Journal of Neurology, Neurosurgery & Psychiatry. 81: e19-e20. DOI: 10.1136/Jnnp.2010.226340.12 |
0.349 |
|
| 2009 |
Stanton BR, Shinhmar D, Turner MR, Williams VC, Williams SC, Blain CR, Giampietro VP, Catani M, Leigh PN, Andersen PM, Simmons A. Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis. Archives of Neurology. 66: 109-15. PMID 19139308 DOI: 10.1001/Archneurol.2008.527 |
0.367 |
|
| 2009 |
Dumont C, Corsoni-Tadrzak A, Ruf S, de Boer J, Williams A, Turner M, Kioussis D, Tybulewicz VL. Rac GTPases play critical roles in early T-cell development. Blood. 113: 3990-8. PMID 19088377 DOI: 10.1182/Blood-2008-09-181180 |
0.319 |
|
| 2009 |
Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. The Lancet. Neurology. 8: 94-109. PMID 19081518 DOI: 10.1016/S1474-4422(08)70293-X |
0.373 |
|
| 2009 |
Scott KM, Abhinav K, Stanton BR, Johnston C, Turner MR, Ampong MA, Sakel M, Orrell RW, Howard R, Shaw CE, Leigh PN, Al-Chalabi A. Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology. 32: 81-8. PMID 19039239 DOI: 10.1159/000177032 |
0.335 |
|
| 2009 |
Simpson CL, Lemmens R, Miskiewicz K, Broom WJ, Hansen VK, van Vught PW, Landers JE, Sapp P, Van Den Bosch L, Knight J, Neale BM, Turner MR, Veldink JH, Ophoff RA, Tripathi VB, et al. Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Human Molecular Genetics. 18: 472-81. PMID 18996918 DOI: 10.1093/Hmg/Ddn375 |
0.34 |
|
| 2008 |
Wicks P, Turner MR, Abrahams S, Hammers A, Brooks DJ, Leigh PN, Goldstein LH. Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 9: 43-9. PMID 18270878 DOI: 10.1080/17482960701737716 |
0.302 |
|
| 2007 |
Turner MR, Hammers A, Allsop J, Al-Chalabi A, Shaw CE, Brooks DJ, Leigh PN, Andersen PM. Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 343-7. PMID 18033592 DOI: 10.1080/17482960701538734 |
0.329 |
|
| 2007 |
Turner MR, Chohan G, Quaghebeur G, Greenhall RC, Hadjivassiliou M, Talbot K. A case of celiac disease mimicking amyotrophic lateral sclerosis. Nature Clinical Practice. Neurology. 3: 581-4. PMID 17914346 DOI: 10.1038/Ncpneuro0631 |
0.307 |
|
| 2007 |
Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, et al. Requirement of bic/microRNA-155 for normal immune function. Science (New York, N.Y.). 316: 608-11. PMID 17463290 DOI: 10.1126/Science.1139253 |
0.301 |
|
| 2007 |
Kasperaviciute D, Weale ME, Shianna KV, Banks GT, Simpson CL, Hansen VK, Turner MR, Shaw CE, Al-Chalabi A, Pall HS, Goodall EF, Morrison KE, Orrell RW, Beck M, Jablonka S, et al. Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain : a Journal of Neurology. 130: 2292-301. PMID 17439985 DOI: 10.1093/Brain/Awm055 |
0.331 |
|
| 2007 |
Turner MR, Rabiner EA, Al-Chalabi A, Shaw CE, Brooks DJ, Leigh PN, Andersen PM. Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS. Neurology. 68: 1233-5. PMID 17420412 DOI: 10.1212/01.Wnl.0000259083.31837.64 |
0.339 |
|
| 2005 |
Turner MR, Osei-Lah AD, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ, Leigh PN, Mills KR. Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1279-85. PMID 16107368 DOI: 10.1136/Jnnp.2004.054429 |
0.328 |
|
| 2005 |
Turner MR, Gerhard A, Al-Chalabi A, Shaw CE, Hughes RA, Banati RB, Brooks DJ, Leigh PN. Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 871-4. PMID 15897516 DOI: 10.1136/Jnnp.2004.047902 |
0.301 |
|
| 2005 |
Turner MR, Rabiner EA, Hammers A, Al-Chalabi A, Grasby PM, Shaw CE, Brooks DJ, Leigh PN. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain : a Journal of Neurology. 128: 896-905. PMID 15689356 DOI: 10.1093/Brain/Awh428 |
0.323 |
|
| 2004 |
Osei-Lah AD, Turner MR, Andersen PM, Leigh PN, Mills KR. A novel central motor conduction abnormality in D90A-homozygous patients with amyotrophic lateral sclerosis. Muscle & Nerve. 29: 790-4. PMID 15170611 DOI: 10.1002/Mus.20032 |
0.323 |
|
| 2004 |
Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiology of Disease. 15: 601-9. PMID 15056468 DOI: 10.1016/J.Nbd.2003.12.012 |
0.336 |
|
| 2004 |
Vigorito E, Bell S, Hebeis BJ, Reynolds H, McAdam S, Emson PC, McKenzie A, Turner M. Immunological function in mice lacking the Rac-related GTPase RhoG. Molecular and Cellular Biology. 24: 719-29. PMID 14701744 DOI: 10.1128/Mcb.24.2.719-729.2004 |
0.307 |
|
| 2003 |
Al-Chalabi A, Scheffler MD, Smith BN, Parton MJ, Cudkowicz ME, Andersen PM, Hayden DL, Hansen VK, Turner MR, Shaw CE, Leigh PN, Brown RH. Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis. Annals of Neurology. 54: 130-4. PMID 12838531 DOI: 10.1002/Ana.10638 |
0.379 |
|
| 2003 |
Turner MR, Parton MJ, Shaw CE, Leigh PN, Al-Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 995-7. PMID 12810805 DOI: 10.1136/Jnnp.74.7.995 |
0.309 |
|
| 2003 |
Turner MR, Al-Chalabi A, Shaw CE, Leigh PN. Riluzole and Motor Neurone Disease Practical Neurology. 3: 160-169. DOI: 10.1046/J.1474-7766.2003.07145.X |
0.306 |
|
| 2002 |
Turner M. The role of Vav proteins in B cell responses Advances in Experimental Medicine and Biology. 512: 29-34. PMID 12405184 DOI: 10.1007/978-1-4615-0757-4_4 |
0.305 |
|
| 2002 |
Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 3: 15-21. PMID 12061944 DOI: 10.1080/146608202317576499 |
0.33 |
|
| 2001 |
Turner MR, Parton MJ, Leigh PN. Clinical trials in ALS: an overview. Seminars in Neurology. 21: 167-75. PMID 11442325 DOI: 10.1055/S-2001-15262 |
0.31 |
|
| 2000 |
Turner MR, Leigh PN. Positron emission tomography (PET)--its potential to provide surrogate markers in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 1: S17-22. PMID 11464936 DOI: 10.1080/14660820052415781 |
0.331 |
|
| 1995 |
Tarakhovsky A, Turner M, Schaal S, Mee PJ, Duddy LP, Rajewsky K, Tybulewicz VL. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature. 374: 467-70. PMID 7700358 DOI: 10.1038/374467A0 |
0.309 |
|
| 1995 |
Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RL, Tybulewicz VL. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 378: 298-302. PMID 7477352 DOI: 10.1038/378298A0 |
0.306 |
|
| Show low-probability matches. |
